So, there is evidence that ATXN2 intermediate polyQ repeat modulates ALS pathophysiology via its RNA-dependent interaction with FUS and TDP-43, but further research is needed to dissect the underlying molecular mechanisms. The gene discussed is TARDBP; the disease is amyotrophic lateral sclerosis.